Searched for
GSK VARIANT
Sanofi, GSK variant-specific Covid-19 shot found effective against Omicron"Sanofi-GSK's vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron varian...- GSK-Vir therapy works against Omicron sub-variant, data suggestsBased on pseudovirus and extensive pharmacokinetic data, the company said it believed the 500 mg dose of sotrovimab is sufficient to retain...
- GSK to increase Covid drug capacity, but no plans for India yetThe company didn't specify any timelines on when the drug will be available in India, or whether it has initiated any discussions with the ...
- India may have to wait longer for Pfizer, GSK's Covid drugsLast month Pfizer had announced an agreement with the UN's Medicines Patent Pool (MPP) for licensing antiviral intellectual property to MPP...
- Omicron more transmissible than Delta: UK PM Boris Johnson to ministersJohnson's official Number 10 Downing Street spokesperson told reporters in an account of the Cabinet meeting that Johnson reiterated it was...
- New data shows GSK-Vir drug works against all Omicron mutationsThe data, yet to be published in a peer-reviewed medical journal, shows that the companies' treatment, sotrovimab, is effective against all...
- GSK says antibody drug 'Sotrovimab' works against OmicronUK's Medicines and Healthcare products Regulatory Agency has approved sotrovimab, a Covid-19 treatment which has been developed by GSK and ...
- Sanofi, GSK receive nod for Phase 3 trial of COVID-19 vaccine candidate in IndiaThe design of the Phase 3 study, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate...
- Sanofi-GSK reports success in Covid-19 vaccine, after setbackThe drugmakers said they plan to begin late-stage trials and production in the coming weeks and hope to win regulatory approval for the vac...
- Vaccine tech transfer hard, next six months key in Covid fight, says leading vaccine makersOn Friday, senior executives from companies such as Moderna, GSK and Bharat Biotech addressed various issues on Covid vaccines, including e...
- GSK sees lower profit this year, split plans on trackThe world's biggest vaccine maker by sales said on Wednesday it expected adjusted earnings to fall by a mid- to high-single digit percentag...
- GSK, CureVac partnership eyes COVID-19 vaccine against multiple variantsGSK, which holds a stake in CureVac, will also support the production of up to 100 million doses of CureVac's first generation COVID-19 vac...
- Danone & Nestle launching a slew of new products in health and nutrition segmentWhile Nestle is re-launching Milo, Danone said it has nearly a dozen new products in its pipeline, like low sugar variants, bar and ready-t...
- Continued pressure on Horlicks, destocking negatively impacted nutrition business: GSK
- Horlicks plays on price points as Nestle, Danone and Abbot bring fight to its doorWhile India is the second largest country after the US in terms of topline for GSK Consumer, the Gurgaon-based firm continues to depend hea...
- GSK halts invoicing of Crocin Cold and FluHealth foods and consumer goods maker GSK Consumer has stopped sale of Crocin Cold & Flu, after the Government announced a ban on sale of f...
- After maggi, more brands come under FSSAI scannerFSSAI on Monday asked all state food regulators to ensure that all the ‘illegal’ products in these fast food categories are “recalled.
- GSK slashes price of Crocin tabletsGSKAP takes care of all non-nutrition products whereas GSK Consumer Healthcare is a listed entity which deals only in nutritional products.
- Glaxo decides to cut price of Crocin by 50 per centGlaxo had stopped manufacturing Crocin from September 2012, and had launched the variant 'Crocin Advance' at a higher price.
- GSK on prowl, to get global productsThe pharma major is close to making key acquisitions in healthcare and OTC and launch new products.
Load More
